Rebecca Frey
Chief Executive Officer, Director · Yarrow Bioscience, Inc.
Individual
- 2026
- Oct 30, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Rebecca Frey's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
- TCO GROUP HOLDINGS, L.P. - $106.38M in INNV purchases and sales in the last 12 months
- IGNITE AGGREGATOR LP - $106.38M in INNV purchases and sales in the last 12 months
- Bruce Booth - $100.59M in KYMR purchases and sales in the last 12 months
- Emily M. Leproust - $100.57M in TWST purchases and sales in the last 12 months
- Catalyst4, Inc. - $98.71M in MPLT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Rebecca Frey?
Rebecca Frey is a corporate insider, tracked as Chief Executive Officer, Director of Yarrow Bioscience, Inc. (YARW). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Rebecca Frey submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.